Type 2 Diabetes Mellitus and COVID-19: A Narrative Review

Frontiers in Endocrinology

Martina Vacca¹  Karen Pinelli¹  Massimo Raspanti¹  Christiano Argano¹  Salvatore Corrao² 

[1] Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, Italy;Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", PROMISE, University of Palermo, Palermo, Italy;

关键词: COVID-19;    SARS-CoV-2;    coronavirus;    diabetes;    chronic conditions;    review;   

DOI  :  10.3389/fendo.2021.609470

来源: DOAJ

【 摘 要 】

The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.

【 授权许可】

Unknown